Literature DB >> 8895871

Effects of pharmacologically facilitating glutamatergic transmission in the trisynaptic intrahippocampal circuit.

J Sirvio1, J Larson, C N Quach, G A Rogers, G Lynch.   

Abstract

The effects of a recently synthesized benzoyl-piperidine drug that enhances currents mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)-type glutamate receptors were tested on monosynaptic and polysynaptic responses in hippocampal slices of the rat. Stimulation of perforant path inputs to the dentate gyrus evoked extracellular responses in field CA1 that had latencies and laminar profiles indicating that they were relayed through the trisynaptic intrahippocampal circuit. Under control conditions, trisynaptic field excitatory postsynaptic potentials did not show larger paired-pulse facilitation than monosynaptic responses and failed to exhibit frequency facilitation. Low concentrations of picrotoxin greatly enhanced trisynaptic responses and, under these conditions, frequency facilitation was obtained. Benzoyl-piperidine-12 (250 microM) had a three-fold greater effect on the amplitude of trisynaptic responses than on monosynaptic field excitatory postsynaptic potentials, indicating that the drug's effect is amplified across the successive stages of a polysynaptic circuit. The AMPA receptor modulator did not change the frequency characteristics of monosynaptic potentials and had only a modest influence on those of the trisynaptic response. The effect of benzoyl-piperidine-12 on trisynaptic responses was significantly greater when GABAergic inhibition was partially blocked with picrotoxin; the GABA blocker did not alter the effects of benzoyl-piperidine-12 on monosynaptic responses. These results indicate that centrally active AMPA receptor modulators are likely to have a greater influence on brain operations involving long chains of connections than on those mediated by simple reflex-like circuits, and will vary markedly in their effects depending upon the excitability of local interneurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895871     DOI: 10.1016/0306-4522(96)00170-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

Review 1.  Challenges for and current status of research into positive modulators of AMPA receptors.

Authors:  Simon E Ward; Benjamin D Bax; Mark Harries
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

2.  Experimental mild traumatic brain injury induces functional alteration of the developing hippocampus.

Authors:  Zhe Yu; Barclay Morrison
Journal:  J Neurophysiol       Date:  2009-11-18       Impact factor: 2.714

3.  Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons.

Authors:  J C Lauterborn; G Lynch; P Vanderklish; A Arai; C M Gall
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

Review 4.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

Review 5.  The likelihood of cognitive enhancement.

Authors:  Gary Lynch; Linda C Palmer; Christine M Gall
Journal:  Pharmacol Biochem Behav       Date:  2011-01-06       Impact factor: 3.533

6.  Short- and long-lasting consequences of in vivo nicotine treatment on hippocampal excitability.

Authors:  Rachel E Penton; Michael W Quick; Robin A J Lester
Journal:  J Neurosci       Date:  2011-02-16       Impact factor: 6.167

Review 7.  Pharmacological enhancement of memory or cognition in normal subjects.

Authors:  Gary Lynch; Conor D Cox; Christine M Gall
Journal:  Front Syst Neurosci       Date:  2014-05-20

8.  Mechanism based approaches for rescuing and enhancing cognition.

Authors:  Gary Lynch; Christine M Gall
Journal:  Front Neurosci       Date:  2013-08-15       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.